Thus, the results of the study show the effectiveness of Suprefort and the practicality of its application
in the complex treatment of patients with diabetes mellitus. However, the use of a complex of peptide
drugs aimed at different parts of the pathogenesis of diabetes mellitus (Suprefort, Cerluten, Endoluten)
has had a more pronounced and long-lasting effect compared with just taking Suprefort. Comparative
analysis of the application of peptide medication in the case of diabetes mellitus shows that it is preferable
to apply this complex of peptides of the pancreas, pineal gland, and brain as part of a complex treatment
and for the prevention of diseases in middle and senior age. These drugs have no side effects, do not
cause complications or addiction. There are no medical contraindications to their use.
Recommended dosages:
Suprefort — 2 capsules per day for 3 months.
Cerluten — 2 capsules per day for 3 months.
Endoluten — 1 capsule per day (in the morning) for 2 months.
It is advisable to repeat courses of treatment every 4-6 months.
Conclusion
Based on the data obtained during the studies, we can conclude that existing conventional treatment
regimens of cerebral atherosclerosis and diabetes mellitus require revision and a new approach. The new
method involves the inclusion of these high-performance schemes, which rely on physiological peptide
drug targeted action aimed at increasing the reserve capacity of the organs and tissues involved in the
pathological processes.
Seoul, South Korea 2013
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.